Skip to main content
Review

Clinical and economic impact of medication reconciliation in cancer patients: a systematic review.

Herledan C, Baudouin A, Larbre V, et al. Clinical and economic impact of medication reconciliation in cancer patients: a systematic review. Support Care Cancer. 2020;28(8):3557-3569. doi:10.1007/s00520-020-05400-5.

Save
Print
April 22, 2020
Herledan C, Baudouin A, Larbre V, et al. Support Care Cancer. 2020;28(8):3557-3569.

This systematic review synthesizes the evidence from 14 studies on medication reconciliation in cancer patients. While the majority of studies did not include a contemporaneous comparison group, they did report that medication reconciliation led to medication error identification (most frequently drug omissions, additions or dosage errors) in up to 88-95% of patients.